Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro

Jorgensen, H G and Allan, E K and Mountford, J C and Richmond, L and Elliott, M A and Holyoake, T L (2004) Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro. Blood, 104 (11). 551A-551A. 1997. ISSN 0006-4971

Full text not available in this repository.Request a copy

Abstract

Meeting abstract 1997 looks at enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro

ORCID iDs

Jorgensen, H G, Allan, E K, Mountford, J C, Richmond, L, Elliott, M A

and Holyoake, T L;

Share and Export

Item metadata

Item type:	Article
ID code:	34850
Dates:	Date Event 16 November 2004 Published
Subjects:	Medicine > Pharmacy and materia medica
Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Depositing user:	Pure Administrator
Date deposited:	21 Nov 2011 15:00
Last modified:	11 Nov 2024 09:55
URI:	https://strathprints.strath.ac.uk/id/eprint/34850

CORE (COnnecting REpositories)